TEN Clinical Trials

2,792 recruitingLast updated: June 18, 2026

There are 2,792 actively recruiting ten clinical trials across 112 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1, Early Phase 1. Top locations include Boston, Massachusetts, United States, Beijing, Beijing Municipality, China, New York, New York, United States. Updated daily from ClinicalTrials.gov.


TEN Trials at a Glance

2,792 actively recruiting trials for ten are listed on ClinicalTrialsFinder across 6 cities in 112 countries. The largest study group is Not Applicable with 1,238 trials, with the heaviest enrollment activity in Boston, Beijing, and New York. Lead sponsors running ten studies include Assistance Publique - Hôpitaux de Paris, Mayo Clinic, and Vanderbilt University Medical Center.

Treatments under study

About TEN Clinical Trials

Looking for clinical trials for TEN? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new TEN trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about TEN clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 2,792 trials

Recruiting
Not Applicable

PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)

Persistent Atrial Fibrillation
Boston Scientific Corporation640 enrolled1 locationNCT07106970
Recruiting
Phase 2Phase 3

Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR Trial

Extensive Stage Lung Small Cell Carcinoma
National Cancer Institute (NCI)138 enrolled416 locationsNCT04402788
Recruiting

WRAP North America

Venous StenosisVenous Occlusion
Merit Medical Systems, Inc.250 enrolled16 locationsNCT06807099
Recruiting
Not Applicable

Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Pulmonary HypertensionBronchopulmonary Dysplasia
University of Alabama at Birmingham39 enrolled2 locationsNCT06373289
Recruiting

Fainting Detection And Early Warning In Syncope Evaluation Study (ARISE)

Orthostatic HypotensionReflex Syncope
Boston Scientific Corporation40 enrolled1 locationNCT07502599
Recruiting
Phase 3

A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Extensive-stage Small-cell Lung Cancer
Bristol-Myers Squibb530 enrolled183 locationsNCT06646276
Recruiting
Phase 2

Study of Pimicotinib in Japanese Participants With Tenosynovial Giant Cell Tumor (TGCT) (J-MANEUVER)

Tenosynovial Giant Cell Tumor
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany20 enrolled3 locationsNCT07499362
Recruiting
Phase 1

A Study of LY3971297 in Healthy Participants

ObesityHypertensionHealthy
Eli Lilly and Company225 enrolled7 locationsNCT06148272
Recruiting

Familial Investigations of Childhood Cancer Predisposition

Pancreatic CancerHereditary Breast and Ovarian CancerHodgkin Lymphoma+43 more
St. Jude Children's Research Hospital1,500 enrolled1 locationNCT03050268
Recruiting
Phase 1Phase 2

A Study to Evaluate DJI136, a DLL3-targeted CAR-T Therapy

Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Novartis Pharmaceuticals80 enrolled3 locationsNCT07564401
Recruiting
Not Applicable

e-ALIGN: A Patient Portal-based Intervention to Align Medications With What Matters Most

DementiaMild Cognitive Impairment (MCI)Potentially Inappropriate Medication Use
Johns Hopkins University100 enrolled1 locationNCT07454824
Recruiting

Detecting Pulmonary Hypertension With the Eko CORE 500 Digital Stethoscope

Pulmnary Hypertension
Eko Devices, Inc.1,513 enrolled2 locationsNCT07136623
Recruiting
Not Applicable

Optical Coherence Tomography Angiography in Subjects With Retinal Vascular Disease

Diabetic RetinopathyHypertension,EssentialRetinal Vein Occlusion+1 more
Johns Hopkins University1,050 enrolled1 locationNCT04505618
Recruiting

Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG

Heart Failure With Reduced Ejection FractionHypertension, Pulmonary
Eko Devices, Inc.3,850 enrolled4 locationsNCT07087613
Recruiting
Phase 3

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Pulmonary Hypertension Due to Lung Disease (Disorder)
Liquidia Technologies, Inc.344 enrolled6 locationsNCT07285655
Recruiting

Development of an Algorithm to Detect Pulmonary Hypertension Using an Electronic Stethoscope

Pulmonary Hypertension
Eko Devices, Inc.2,420 enrolled3 locationsNCT05873387
Recruiting
Not Applicable

Continuous Versus Bolus Norepinephrine Administration to Treat Postinduction Hypotension

Postinduction Hypotension
Universitätsklinikum Hamburg-Eppendorf446 enrolled4 locationsNCT07538388
Recruiting
Not Applicable

Virtual Reality Mirror Therapy With Focused Object-Directed Attention System

Virtual RealityStrokeRehabilitation+3 more
National Cheng-Kung University Hospital54 enrolled1 locationNCT07525713
Recruiting

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Pulmonary DiseasePulmonary Hypertension
National Institutes of Health Clinical Center (CC)270 enrolled1 locationNCT01730092
Recruiting

Diabetes and Heart Disease Risk in Blacks

ObesityCardiovascular DiseasesHypertension+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2,000 enrolled1 locationNCT00001853